Mapping technological capabilities into product markets and competitive advantage: the case of cholesterol drugs
Year: 2002
Type: article
Abstract: While a lot of attention has been paid to those characteristics of capabilities that give firms a competitive advantage, a lot less attention has been given to supporting empirical evidence and to the deployment of these capabilities. This paper presents a model for mapping firm capabilities into customer value and competitive advantage in different markets. With empirical evidence from cholesterol drugs, I illustrate how the model can be used to estimate customer value and competitive advantage from technological capabilities. Copyright © 2002 John Wiley & Sons, Ltd.
Source: Strategic Management Journal
DOI: 10.1002/smj.221
Author: Allan Afuah
Institution: University of Michigan
Language: English
Subfield: Strategy and Management
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W1966316787
